Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Frey

Showing results (461-470 of 475) with videos related to

Pageof 48
Sort By:
Clinical Pharmacology and Therapeutics|January 22, 2023
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 StudyLeen Magarbeh, Claudia Hassel, Maximilian Choi, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 9, 2022
Effective recommendations towards healthy routines to preserve mental health during the COVID-19 pandemicLuísa K Pilz, Natividade S Couto Pereira, Ana Paula Francisco, et al.
Frontiers in Psychiatry|February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain DisordersAnthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
Nature Communications|May 23, 2017
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genesJuan Pablo Lopez, Laura M Fiori, Cristiana Cruceanu, et al.
BMC Psychiatry|April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohortRaymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatalsSimone N Vigod, Benicio N Frey, Crystal T Clark, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 6, 2022
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designsMiriam von Mücke Similon, Cecilia Paasche, Fas Krol, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 7, 2024
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultesRaymond W Lam, Sidney H Kennedy, Camelia Adams, et al.
BMC Psychiatry|January 23, 2023
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationaleCynthia H Y Fu, Guray Erus, Yong Fan, et al.
Pageof 48

Showing results (461-470 of 475) with videos related to

Sort By:
Pageof 48
Clinical Pharmacology and Therapeutics|January 22, 2023
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 StudyLeen Magarbeh, Claudia Hassel, Maximilian Choi, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 9, 2022
Effective recommendations towards healthy routines to preserve mental health during the COVID-19 pandemicLuísa K Pilz, Natividade S Couto Pereira, Ana Paula Francisco, et al.
Frontiers in Psychiatry|February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain DisordersAnthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
Nature Communications|May 23, 2017
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genesJuan Pablo Lopez, Laura M Fiori, Cristiana Cruceanu, et al.
BMC Psychiatry|April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohortRaymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatalsSimone N Vigod, Benicio N Frey, Crystal T Clark, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 6, 2022
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designsMiriam von Mücke Similon, Cecilia Paasche, Fas Krol, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 7, 2024
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultesRaymond W Lam, Sidney H Kennedy, Camelia Adams, et al.
BMC Psychiatry|January 23, 2023
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationaleCynthia H Y Fu, Guray Erus, Yong Fan, et al.
Pageof 48